
DarshanTalks Podcast
Welcome to DarshanTalks!
We demystify fraud for legal, regulatory, and compliance essentials in the life sciences and pharmacy industries. Through engaging 15-30-minute interviews with influential change makers, short educational regulatory defbriefs, and 60 second audio takeaways, we unveil the strategies behind bringing drugs and devices to market—and keeping them there!
Powered By The Kulkarni Law Firm - Helping regulators see your business the way you do.
We focus on life science issues involving medical affairs, marketing and advertising, and clinical research so that you can learn about the industry, enhance your business and grow your career.
DarshanTalks Podcast
NIH Grant Denials Ruled Discriminatory?
Darshan Kulkarni and Edye Edens break down a recent federal court ruling that challenges the NIH’s decision to halt grant funding for projects focused on LGBTQ+ populations and DEI-related research. The judge ruled that cutting off funding solely on a discriminatory basis—such as the subject matter being DEI or LGBTQ+ related—may itself be unconstitutional. While this has sparked optimism among affected researchers, Edye and Darshan caution that this is just one step in a longer legal process and not a final resolution. Appeals are expected, and the ruling could be reversed or narrowed.
The episode explores broader implications for clinical research and federal grant recipients. They stress that this case is about discriminatory decision-making, not a reversal of all NIH funding cuts. They advise institutions and research sites to remain cautious—don’t make financial or operational decisions based on the assumption that funding will be restored.
Ultimately, this episode highlights a potential shift in how courts may view the intersection of politics, discrimination, and scientific research funding. And it sets the stage for their next discussion on the broader implications of the “Big Beautiful Bill” that’s reshaping the federal research landscape.